Effect of melatonin receptor agonist on treatment of nCPAP

Effect of melatonin receptor agonist on treatment of nCPAP - Ramelteon-SAS study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009511

Enrollment

Registered

2012-12-10

Start date

2012-12-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea Syndrome

Interventions

treatment with ramelteon treatment with ramelteon and benzylpiperazine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with moderate sleep apnea syndrome with treatment of nCPAP

Exclusion criteria

Exclusion criteria: patients with contraindication for sleep medicine

Design outcomes

Primary

Measure	Time frame
Adhearance of nCPAP after treatment with ramelteon	—

Countries

Japan

Contacts

Public ContactKoichi Fukunaga

Keio University School of Medicine Internal Medicine (Pulmonary)

k-fuku@jf7.so-net.ne.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026